New insights for IL-6 targeted therapy as an adjuvant treatment for non-small-cell lung cancer

Author： Zarogoulidis Paul   Yarmus Lonny   Zarogoulidis Konstantinos  

Publisher： Future Science

ISSN： 2041-5990

Source： Therapeutic Delivery, Vol.4, Iss.10, 2013-10, pp. : 1221-1223

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vandetanib for the treatment of non-small-cell lung cancer

By Wong Hui-li   de Boer Richard H  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 14, 2011-10 ,pp. : 2271-2278

Informa Healthcare

Access to resources Recommend Favorite

Dacomitinib, a new therapy for the treatment of non-small cell lung cancer

By Brzezniak Christina   Carter Corey A   Giaccone Giuseppe  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 2, 2013-02 ,pp. : 247-253

Informa Healthcare

Access to resources Recommend Favorite

Non-small cell lung cancer: from targeted therapy to tailored therapy

By Malgieri Simona   Feliciano Salvatore   Bosso Davide   Federico Piera   Palmieri Giovannella   De Placido Sabino   Di Lorenzo Giuseppe   Buonerba Carlo  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 13, 2012-09 ,pp. : 1817-1819

Informa Healthcare

Access to resources Recommend Favorite

Adjuvant Treatment in Non-Small Cell Lung Cancer: Where Are We Now?

By Juergens Rosalyn A.   Brahmer Julie R.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 6, 2006-07 ,pp. : 595-600

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Recent advances in targeted therapy for non-small cell lung cancer

By Ramalingam Suresh   Belani Chandra P  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 2, 2007-02 ,pp. : 245-257

Informa Healthcare

Access to resources Recommend Favorite